CERBAI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.925
EU - Europa 14.644
AS - Asia 9.273
SA - Sud America 1.111
Continente sconosciuto - Info sul continente non disponibili 328
AF - Africa 286
OC - Oceania 192
Totale 47.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.558
RU - Federazione Russa 4.328
IT - Italia 3.372
SG - Singapore 2.741
PL - Polonia 2.616
CN - Cina 2.006
HK - Hong Kong 1.548
IE - Irlanda 1.067
VN - Vietnam 948
BR - Brasile 906
SE - Svezia 862
KR - Corea 775
DE - Germania 497
FR - Francia 434
FI - Finlandia 426
GB - Regno Unito 336
IN - India 324
UA - Ucraina 306
CA - Canada 228
AU - Australia 186
JP - Giappone 171
JO - Giordania 146
TR - Turchia 134
ID - Indonesia 104
BD - Bangladesh 103
AR - Argentina 83
CI - Costa d'Avorio 78
NL - Olanda 76
MX - Messico 67
CH - Svizzera 66
IQ - Iraq 64
ES - Italia 61
BE - Belgio 54
NG - Nigeria 54
ZA - Sudafrica 50
EC - Ecuador 33
AT - Austria 29
VE - Venezuela 23
LT - Lituania 22
PK - Pakistan 21
SC - Seychelles 21
CO - Colombia 20
PH - Filippine 20
CL - Cile 19
GR - Grecia 18
MA - Marocco 18
SA - Arabia Saudita 18
UZ - Uzbekistan 17
RO - Romania 15
DZ - Algeria 14
TH - Thailandia 14
TW - Taiwan 14
CZ - Repubblica Ceca 12
MY - Malesia 12
PY - Paraguay 12
CR - Costa Rica 11
EG - Egitto 11
HN - Honduras 11
KE - Kenya 11
JM - Giamaica 10
NP - Nepal 10
TN - Tunisia 10
IL - Israele 9
KZ - Kazakistan 9
PE - Perù 9
AZ - Azerbaigian 8
PR - Porto Rico 7
BJ - Benin 6
DO - Repubblica Dominicana 6
IR - Iran 6
KW - Kuwait 6
OM - Oman 6
BB - Barbados 5
GE - Georgia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
HU - Ungheria 4
LB - Libano 4
NO - Norvegia 4
PT - Portogallo 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BG - Bulgaria 3
BH - Bahrain 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 47.397
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.785
Ashburn 2.638
Warsaw 2.604
Singapore 1.971
Fairfield 1.918
Hong Kong 1.292
Chandler 1.093
Dublin 1.058
Woodbridge 929
Cambridge 790
Seattle 779
Seoul 764
Houston 709
Milan 681
San Jose 661
Wilmington 635
Beijing 505
Jacksonville 431
Ann Arbor 412
Florence 399
Council Bluffs 396
Altamura 348
Lawrence 348
The Dalles 327
Hefei 304
Princeton 291
Ho Chi Minh City 281
Rome 272
Buffalo 266
Dallas 266
Los Angeles 262
Lauterbourg 244
Boston 224
Boardman 207
Hanoi 198
Mumbai 190
Munich 183
Moscow 180
Melbourne 168
Tokyo 158
New York 136
San Diego 127
Medford 125
Helsinki 112
Izmir 97
Shanghai 97
Falls Church 94
São Paulo 87
Paris 84
Abidjan 78
Kent 77
London 75
Jakarta 71
Turku 69
Norwalk 67
Naples 63
Bern 62
Dong Ket 62
Bologna 59
Redondo Beach 57
Toronto 55
Chicago 54
Frankfurt am Main 54
Abuja 52
Columbus 52
Orem 52
Brussels 51
Turin 50
Guangzhou 49
Clifton 48
Montreal 48
Figino 43
Haiphong 39
Da Nang 36
Dearborn 36
Phoenix 36
Chennai 33
Palermo 32
Tianjin 32
Hillsboro 30
Amsterdam 29
Andover 26
Atlanta 26
Brooklyn 26
Yubileyny 26
Johannesburg 25
Mexico City 25
Miano 25
Venice 25
Denver 23
Poplar 23
Brasília 22
Genoa 22
Rio de Janeiro 22
Vienna 21
Baghdad 20
Belo Horizonte 20
Falkenstein 20
Manchester 20
Scandicci 19
Totale 32.213
Salva come PNG Salva come JPEG
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 492
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 440
Atrial Remodeling in Hypertrophic Cardiomyopathy 410
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 379
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes 363
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 353
Mesoscopic optical imaging of whole mouse heart 352
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 342
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 327
New isoform-selective HCN blockers 325
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 305
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 300
Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction 296
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 296
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach 292
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats 287
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 283
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 283
Antiarrhythmic properties of naloxone: an electrophysiological study on sheep cardiac Purkinje fibers 281
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 280
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 277
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 275
Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. 273
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 266
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 265
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 265
Losartan ameliorates diabetic vascular hyper-reactivity to angiotensin II by reducing ROCK1 expression and activity 264
The funny current in cardiac non-pacemaker cells: functional role and pharmacological modulation 260
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 249
Design of muscle contraction assist devices by liquid crystalline elastomers 248
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 246
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 246
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 236
Action potential propagation in transverse-axial tubular system is impaired in heart failure 234
Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function 232
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 231
Real-time optical manipulation of cardiac conduction in intact hearts 231
Ethical-legal aspects of organoids and their use in research. Manage risks and legal constraints for the development of ethical research 229
Arrhythmia susceptibility in a rat model of acute atrial dilation 228
Electrophysiological Characterization of Isolated Human Atrial Myocytes Exposed to Tegaserod 224
Ranolazine normalizes action potential duration in angiotensin II exposed HL-1 cells: role of late sodium current 222
Prenatal exposure to carbon monoxide delays postnatal cardiac maturation. 219
Modulation of Cardiac Ionic Homeostasis by 3-Iodothyronamine. 218
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 217
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 216
Long term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. 216
A molecular basis for HCN channel over-expression. 212
Acute appendicitis in a patient immunised with COVID-19 vaccine: a case report with morphological analysis 210
Molecular and functional development of cardiomyocytes differentiated from human embryonic stem cells. 209
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 209
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 209
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 207
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 207
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 206
Impact of detubulation on force and kinetics of cardiac muscle contraction 202
Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure 200
The transverse-axial tubular system of cardiomyocytes. 196
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 195
SELECTIVITY OF DIFFERENT CALCIUM ANTAGONISTS ON T- AND L-TYPE CALCIUM CURRENTS IN GUINEA-PIG VENTRICULAR MYOCYTES. 194
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 193
Functional expression and subcellular localization of f-channels in native human and HESC-derived cardiomyocytes 192
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factors 192
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 192
NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. 190
New phenylalkylamines as isoform selective HCN-Channels blockers 190
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling 190
Optical clearing in cardiac imaging: A comparative study 190
Whole heart cytoarchitecture at micron-scale resolution 189
Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy 189
Atrial natriuretic peptide modulates the hyperpolarization-activated current (I(f)) in human atrial myocytes. 189
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 188
Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. 187
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 187
R4496C RyR2 mutation impairs atrial and ventricular contractility 186
5-HT2 receptors enable cardiac differentiation of mouse embryonic stem cells 186
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 184
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 183
AUTONOMIC NERVOUS SYSTEM AND ARRHYTHMOGENESIS 183
Electrophysiological effects mediated by the stimulation of cardiac β2-adrenoceptors with tulobuterol 182
Molecular basis of funny current (If) in normal and failing human heart. 181
If channels as a therapeutic target in heart disease 180
Endothelin-1 promotes cellular electrophysiological remodeling by affecting IKr expression in cardiac HL-1 cells. 180
CHARACTERISTICS OF L-TYPE CALCIUM CHANNEL BLOCKADE BY LACIDIPINE IN GUINEA-PIG VENTRICULAR MYOCYTES 179
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 179
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 178
Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications 177
Functional remodeling in post-myocardial infarcted rats: focus on beta-adrenoceptor subtypes. 176
Microled Illumination Towards Liquid Crystalline Elastomers Based Cardiac Contraction Assistance 176
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 175
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 175
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 175
Action potential modelling predicts electrophysiological and pharmacological features of human embryonic stem cell-derived cardiomyocytes. 174
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 174
Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin 171
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 170
Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue. 170
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 169
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 169
Beta1 and Beta2 adrenoceptors in human ventricular myocytes: a study of their proportion and signaling pathways. 168
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels 167
Totale 23.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.017 0 184 171 83 93 107 93 130 123 95 359 579
2022/20234.845 477 904 185 308 427 896 580 245 528 43 135 117
2023/20241.696 96 225 308 88 105 195 84 320 28 63 91 93
2024/202512.055 442 1.375 844 1.727 3.225 1.533 217 842 634 315 467 434
2025/202614.622 1.336 1.926 1.071 1.137 1.509 712 1.771 813 1.117 888 402 1.940
2026/2027868 400 468 0 0 0 0 0 0 0 0 0 0
Totale 47.759